Presence of Kaposi's Sarcoma and of Behcet’s Disease Concomitantly in a Patient

Murthy MS; Cody Lawrence; Todd Brown; Shanika Sharma

doi:10.26440/IHRJ/0611.02591

Murthy MS
Cody Lawrence
Todd Brown
Shanika Sharma

DOI: https://doi.org/10.26440/IHRJ/0611.02591

Keywords: Behcet Disease, Iatrogenic Kaposi Sarcoma, Immunosuppressive Therapy

Abstract

Iatrogenic Kaposi’s sarcoma is a subtype of Kaposi’s sarcoma (KS), which is a vascular malignant tumor and is seen in organ transplant recipients and in patients receiving immunosuppressive therapy due to other reasons. We describe a case of Behcet's disease associated with Kaposi's sarcoma occurring simultaneously in a 50-year-old male patient. Colchicine and steroids were administered for his mucocutaneous findings and polyarthritis. In few months on therapy, four symmetric, brown- red coloured, asymptomatic macules developed on the inner surface of his left foot. In histopathologic specimens; CD34 positive, atypical spindle cells with swollen nuclei formed bundles and vascular spaces filled with erythrocytes. The patient was diagnosed as KS clinically and histopathologically. HHV-8 DNA was positive with PCR. Regression was observed in the lesions after the cessation of corticosteroid treatment.

Downloads

Download data is not yet available.

Author Biographies

Murthy MS

MD (Internal Medicine), Private Practitioner, Roy, Utah, United States of America.

Cody Lawrence

MD (Internal Medicine), Private Practitioner, Roy, Utah, United States of America.

Todd Brown

MBBS, Private Practitioner, Pokhara, Nepal, India.

Shanika Sharma

MBBS, Private Practitioner, Pokhara, Nepal, India.

References

Martin RW, Hood AF, Farmer ER. Kaposi sarcoma. Medicine 1993;72:245-61.

Martin JN, Ganem DE, Osmand DH, et al. Sexual transmission and the natural history of human herpes virus 8 infection. N Engl J Med. 1998;338:948-54.

Ersoy Evans S, Sahin S. Kaposi Sarcoma. Türkiye Klinikleri J Int Med 2007;3:38-43

Farge D. Kaposi’s sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of France. Eur J Med. 1993;2:339-43.

Louthrenoo W, Kasitanon N, Mahanuphab P, et al. Kaposi’s sarcoma in rheumatic disease. Semin Arthritis Rheum. 2003;32:326-33.

Chang Y, Caserman E, Pessin MS, et al. Identification of herpesvirus like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994;266:1865-9.

Henry M, Uthman A, Geusau A, Rieger A, Furci L, at al. Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi’s sarcoma. J Invest Dermatol. 1999;113:613-6.

Blauvelt A. Skin disease associated with human herpes virus 6, 7, 8 infection. J Investig Dermatol Symp Proc. 2001;6:197-202.

Hudnall SD, Rady PL, Tyring SK, et al. Hydrocortisone activation of human herpes virus 8 viral DNA replication and gene expression in vitro. Transplantation 1999;67:648-52.

Deschênes I, Dion L, Beauchesne C, et al. Kaposi’s sarcoma following immune suppressive therapy for Wegener’s granulomatosis. J Rheumatol 2003;30:622-4.

Mezalek TZ, Harmouche H, El Atar N, at al. Kaposi’s sarcoma in association with Behcet’s disease: Case report in literature review. J Semin Arthritis. 2007;36:328-31.

Goedert JJ, Vitale F, Lauria C, at al. Risk factors for classical Kaposi’s sarcoma. J Natl Cancer Inst. 2002;94:1712-8.

Guo WX, Antakly T, Cadotte M, et al. Expression and cytokine regulation of glucocorticoid receptors in Kaposi’s sarcoma. Am J Pathol. 1996;148:1999-2008.